Method for screening an agent for ability to inhibit heparanase activity
AssigneeHoffmann-La Roche Inc.
InventorsKuo-Sen Huang, Anthony Neri, John Lawson Roberts
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoffmann-La Roche Inc.
InventorsKuo-Sen Huang, Anthony Neri, John Lawson Roberts
Estimating the term…
The present invention provides a method for testing an agent for its potential to inhibit heparanase catalytic activity, comprising the steps of: interacting immobilized heparanase substrate binding protein on a solid support with labeled heparanase substrate to provide immobilized labeled heparanase substrate, interacting a heparanase enzyme solution with the immobilized labeled heparanase substrate in the presence of the agent, and detecting the presence or absence of label in the solution remote from the solid support. The labeled heparanase substrate may be bound to an immobilization bridge which binds to immobilized molecules on a solid support, to provide bridge-immobilized labeled heparanase substrate. The present invention also provides a method for testing an agent for its ability to inhibit binding between fibroblast growth factor (FGF) and heparanase substrate, comprising the steps of: interacting in solution immobilized FGF on a solid support with the agent and labeled heparanase substrate, and detecting the presence or absence of label in the solution remote from the solid support.
A method for testing an agent for its potential to inhibit heparanase catalytic activity, comprising the steps of:
A method for testing an agent for its potential to inhibit heparanase catalytic activity, comprising the steps of:
A method for testing an agent for its ability to inhibit binding between fibroblast growth factor (FGF) and heparanase substrate, comprising the steps of:
Dependencies are inferred from the claim text.